Skip to main content
PMC home page
Tobacco Control logoLink to Tobacco Control
. 2000 Sep;9(3):327–333. doi: 10.1136/tc.9.3.327

Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit

K Fagerstrom 1, J Hughes 1, T Rasmussen 1, P Callas 1
PMCID: PMC1748373  PMID: 10982578

Abstract

OBJECTIVE—To monitor the effect of a novel nicotine delivery device that may produce fewer carcinogens (Eclipse) on cigarette smoking, carbon monoxide and nicotine concentrations, and motivation to give up smoking. The smoker's own brand of cigarette and a nicotine replacement product (Nicotrol inhaler) were used as comparisons.
DESIGN—After baseline data were recorded, smokers were randomised to either Eclipse or inhaler for two weeks and then switched to the other product for another two weeks. Thereafter a second baseline was obtained.
SETTING AND PARTICIPANTS— Fifty smokers were included and data are reported for the 40 with complete data sets. The smokers were not trying to quit but were interested in trying a new product to reduce their risk. They visited a smoking clinic 10 times during the six week period of the trial.
INTERVENTION—No counselling to aid reduction by Eclipse or inhaler was given.
MAIN OUTCOME MEASURES—At each visit smoking status and carbon monoxide concentrations were recorded. In half of the visits withdrawal symptoms, attitudes towards smoking, heart rate, and blood nicotine concentrations were also recorded.
RESULTS—Eclipse use decreased the number of cigarettes smoked per day (cpd) from 19.1 cpd at baseline to 2.1 cpd (p < 0.001), but increased carbon monoxide concentrations in parts per million (ppm) from 21.0 ppm to 33.0 ppm (p < 0.001). A similar decrease in cigarettes smoked per day was seen with the Nicotrol inhaler, from 19.1 cpd to 4.8 cpd (p < 0.001), but carbon monoxide decreased from 21.0 ppm to 12.7 ppm (p < 0.001). The blood nicotine concentration remained fairly stable with Eclipse, increasing slightly from 16.8 ng/ml to 18.0 ng/ml, while for the inhaler a significant drop was noted, from 16.8 ng/ml to 12.2 ng/ml (p < 0.002). Craving and withdrawal did not increase with Eclipse. Few significant adverse events occurred with Eclipse.
CONCLUSIONS—Eclipse can dramatically decrease cigarette consumption without causing withdrawal symptoms or decreases in nicotine concentrations or motivation to quit altogether. Unlike the inhaler, Eclipse produces an increase in carbon monoxide concentration. Thus Eclipse may not be a safer cigarette.


Keywords: tobacco; nicotine; harm reduction; nicotine replacement

Full Text

The Full Text of this article is available as a PDF (153.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benowitz N. L., Gourlay S. G. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997 Jun;29(7):1422–1431. doi: 10.1016/s0735-1097(97)00079-x. [DOI] [PubMed] [Google Scholar]
  2. Cone E. J., Henningfield J. E. Premier 'smokeless cigarettes' can be used to deliver crack. JAMA. 1989 Jan 6;261(1):41–41. [PubMed] [Google Scholar]
  3. Fagerström K. O., Tejding R., Westin A., Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tob Control. 1997 Winter;6(4):311–316. doi: 10.1136/tc.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerström K. O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
  5. Hughes J. R. Harm-reduction approaches to smoking. The need for data. Am J Prev Med. 1998 Jul;15(1):78–79. doi: 10.1016/s0749-3797(98)00033-6. [DOI] [PubMed] [Google Scholar]
  6. Jiménez-Ruiz C., Kunze M., Fagerström K. O. Nicotine replacement: a new approach to reducing tobacco-related harm. Eur Respir J. 1998 Feb;11(2):473–479. doi: 10.1183/09031936.98.11020473. [DOI] [PubMed] [Google Scholar]
  7. Lunell E., Molander L., Leischow S. J., Fagerström K. O. Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms. Eur J Clin Pharmacol. 1995;48(3-4):235–240. doi: 10.1007/BF00198304. [DOI] [PubMed] [Google Scholar]
  8. Pauly J. L., Lee H. J., Hurley E. L., Cummings K. M., Lesses J. D., Streck R. J. Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):967–979. [PubMed] [Google Scholar]
  9. Smith C. J., McKarns S. C., Davis R. A., Livingston S. D., Bombick B. R., Avalos J. T., Morgan W. T., Doolittle D. J. Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat Res. 1996 Sep 26;361(1):1–9. doi: 10.1016/s0165-1161(96)90222-8. [DOI] [PubMed] [Google Scholar]
  10. Stapleton J. A., Russell M. A., Sutherland G., Feyerabend C. Nicotine availability from Eclipse tobacco-heating cigarette. Psychopharmacology (Berl) 1998 Oct;139(3):288–290. doi: 10.1007/s002130050719. [DOI] [PubMed] [Google Scholar]
  11. Tang J. L., Morris J. K., Wald N. J., Hole D., Shipley M., Tunstall-Pedoe H. Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. BMJ. 1995 Dec 9;311(7019):1530–1533. doi: 10.1136/bmj.311.7019.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wald N., Howard S., Smith P. G., Kjeldsen K. Association between atherosclerotic diseases and carboxyhaemoglobin levels in tobacco smokers. Br Med J. 1973 Mar 31;1(5856):761–765. doi: 10.1136/bmj.1.5856.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Warner K. E., Slade J., Sweanor D. T. The emerging market for long-term nicotine maintenance. JAMA. 1997 Oct 1;278(13):1087–1092. [PubMed] [Google Scholar]
  14. deBethizy J. D., Borgerding M. F., Doolittle D. J., Robinson J. H., McManus K. T., Rahn C. A., Davis R. A., Burger G. T., Hayes J. R., Reynolds J. H., 4th Chemical and biological studies of a cigarette that heats rather than burns tobacco. J Clin Pharmacol. 1990 Aug;30(8):755–763. doi: 10.1002/j.1552-4604.1990.tb03639.x. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES